Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The . gov means it’s official. Federal government websites often end in . gov or . mil. Before sharing sensitive information, make sure you’re on a federal government site VSports app下载. .

Https

The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely V体育官网. .

Review
. 2007 Feb 23;3(2):e12.
doi: 10.1371/journal.pcbi.0030012.

From bytes to bedside: data integration and computational biology for translational cancer research

Affiliations
Review

From bytes to bedside: data integration and computational biology for translational cancer research

Jomol P Mathew et al. PLoS Comput Biol. .
No abstract available

PubMed Disclaimer

Conflict of interest statement (V体育安卓版)

Competing interests. The authors have declared that no competing interests exist VSports手机版.

"VSports app下载" Figures

Figure 1
Figure 1. Data Integration for Translational Cancer Research
Archival of clinical and molecular data in easily retrievable standardized formats, aggregation, integration, and data analysis will provide opportunities for the next-generation biomedical discoveries that can impact cancer research and treatment.
Figure 2
Figure 2. Protein Profiling for Cancer Diagnosis and Prognosis
Generation of protein profiles using mass spectrometry is an example of an experimental technique that produces massive amounts of data that is difficult to interpret without computational and statistical algorithms. For instance, comparison of disease versus control sample profiles can lead to identification of disease-specific protein expression signatures, which could be used as diagnostic or prognostic markers. Aggregation of such data from multiple sources and pooled analysis requires proper annotation of sample source, sample handling, and experiment information.

VSports手机版 - References

    1. von Mehren M, Adams GP, Weiner LM. Monoclonal antibody therapy for cancer. Annu Rev Med. 2003;54:343–369. - PubMed
    1. FDA. Challenge and opportunity on the critical path to new medical products. US Federal Drug Administration; 2004. Available: http://www.fda.gov/oc/initiatives/criticalpath/whitepaper.pdf (V体育安卓版). Accessed 25 December 2006.
    1. Fabian MA, Biggs WH, III, Treiber DK, Atteridge CE, Azimioara MD, et al. A small molecule–kinase interaction map for clinical kinase inhibitors. Nat Biotechnol. 2005;23:329–336. - PubMed
    1. McNeil N, Ried T. Novel molecular cytogenetic techniques for identifying complex chromosomal rearrangements: Technology and applications in molecular medicine. Expert Rev Mol Med. 2000;2000:1–14. - "V体育官网" PubMed
    1. Baldwin C, Garnis C, Zhang L, Rosin MP, Lam WL. Multiple microalterations detected at high frequency in oral cancer. Cancer Res. 2005;65:7561–7567. - PubMed

Substances